XML 20 R11.htm IDEA: XBRL DOCUMENT v3.20.1
GOODWILL AND OTHER INTANGIBLE ASSETS
3 Months Ended
Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL AND OTHER INTANGIBLE ASSETS
Goodwill
Changes in the carrying amount of goodwill for the three-month period ended March 31, 2020 were as follows:
 
Codman Specialty
Surgical
 
Orthopedics and
Tissue Technologies
 
Total
 
(In thousands)
Goodwill at December 31, 2019
$
653,500

 
$
300,780

 
$
954,280

Foreign currency translation
(1,867
)
 
(859
)
 
(2,726
)
Goodwill at March 31, 2020
$
651,633

 
$
299,921

 
$
951,554


The components of the Company’s identifiable intangible assets were as follows:
 
March 31, 2020
 
Weighted
Average
Life
 
Cost
 
Accumulated
Amortization
 
Net
 
(Dollars in thousands)
Completed technology
19 years
 
$
881,856

 
$
(225,350
)
 
$
656,506

Customer relationships
12 years
 
221,193

 
(123,896
)
 
97,297

Trademarks/brand names
28 years
 
103,472

 
(29,190
)
 
74,282

Codman tradename
Indefinite
 
163,680

 

 
163,680

Supplier relationships
27 years
 
34,721

 
(18,304
)
 
16,417

All other(1)
4 years
 
10,787

 
(4,742
)
 
6,045

 
 
 
$
1,415,709

 
$
(401,482
)
 
$
1,014,227


 
December 31, 2019
 
Weighted
Average
Life
 
Cost
 
Accumulated
Amortization
 
Net
 
(Dollars in thousands)
Completed technology
19 years
 
$
880,623

 
$
(213,702
)
 
$
666,921

Customer relationships
12 years
 
222,575

 
(119,393
)
 
103,182

Trademarks/brand names
28 years
 
103,873

 
(28,514
)
 
75,359

Codman tradename
Indefinite
 
163,126

 

 
163,126

Supplier relationships
27 years
 
34,721

 
(17,947
)
 
16,774

All other (1)
4 years
 
10,869

 
(4,640
)
 
6,229

 
 
 
$
1,415,787

 
$
(384,196
)
 
$
1,031,591



(1)
At March 31, 2020 and December 31, 2019, all other included IPR&D of $1.0 million, which was indefinite-lived.
Based on quarter-end exchange rates, amortization expense (including amounts reported in cost of product revenues) is expected to be approximately $56.1 million for the remainder of 2020, $64.4 million in 2021, $60.8 million in 2022, $60.0 million in 2023, $59.2 million in 2024, $59.1 million in 2025 and $491.9 million thereafter.